📰 Van Cutsem News
Page 5 - Van Cutsem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Van Cutsem. Real-time updates on events, politics, business and more.
May 14, 2023
From a Bohemian ceramicist to a Marines heartthrob and glamorous Lady Margarita Armstrong-Jones, who turns 21 today, a look at Princess Margarets free-spirited grandchildren.
May 11, 2023
Kate Middleton and Prince William's bridesmaid Eliza Lopes returned to Westminster Abbey 12 years after her starring role at the 2011 royal wedding. See pictures....
May 5, 2023
I was in London when the Queen died, and my husband was at home in Cornwall. I texted him with the news. He replied simply: God save the King!
May 5, 2023
Up until now, Queen Camilla has attempted to keep her own family from her marriage to Andrew Parker Bowles largely away from the royal spotlight.
April 18, 2023
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
April 15, 2023
Targeting CLDN18.2 with zolbetuximab significantly prolonged progression-free survival and overall survival when combined with mFOLFOX6 versus placebo plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Zolbetuximab plus mFOLFOX6 might represent a new first-line treatment in these patients.
April 12, 2023
With an overall 5-year survival rate of under 15% in patients with metastatic colorectal cancer, investigators have sought to parse mutational analyses to increase gains.
April 12, 2023
Advancements in the treatment of colorectal cancer have undoubtedly been made in recent years, but unfortunately, they are not enough to combat this...
April 11, 2023
MINNEAPOLIS, April 11, 2023 -- Panbela Therapeutics, Inc. , a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical... | April 11, 2023
April 4, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for